Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment
- 1 August 2014
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 47 (12) , 1056-1059
Abstract
No abstract availableKeywords
Funding Information
- Warszawski Uniwersytet Medyczny
This publication has 37 references indexed in Scilit:
- Delayed Diagnosis of HCC with Chronic Alcoholic Liver DiseaseLiver Cancer, 2012
- Changes in arginase isoenzymes pattern in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2008
- Liver cirrhosisThe Lancet, 2008
- Liver I/R injury is improved by the arginase inhibitor, Nω-hydroxy-nor-l-arginine (nor-NOHA)American Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Hepatocellular carcinomaCurrent Opinion in Gastroenterology, 2005
- Regulation of Nitric Oxide Production by Arginine Metabolic EnzymesBiochemical and Biophysical Research Communications, 2000
- ARGINASE RELEASE FOLLOWING LIVER REPERFUSION EVIDENCE OF HEMODYNAMIC ACTION OF ARGINASE INFUSIONSTransplantation, 1995
- L-ARGININE DEFICIENCY AFTER LIVER TRANSPLANTATION AS AN EFFECT OF ARGINASE EFFLUX FROM THE GRAFTTransplantation, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970